Safety and feasibility of percutaneous retrograde coronary sinus delivery of autologous bone marrow mononuclear cell transplantation in patients with chronic refractory angina

Journal of Translational Medicine

Volumn 9, Issue 1, 2011, Pages

  Tuma, Jorge ^a   Fernández Viña, Roberto ^b   Carrasco, Antonio ^c   Castillo, Jorge ^c   Cruz, Carlos ^a   Carrillo, Alvaro ^a   Ercilla, Jose ^a   Yarleque, Carlos ^a   Cunza, Jaime ^a   Henry, Timothy D ^d   Patel, Amit N ^e  

^a Brasil   (Peru)

^b Centro Cardiovascular San Nicolás   (Argentina)

^c Instituto de Criopreservació n y Terapia Celular   (Peru)

^d ABBOTT NORTHWESTERN HOSPITAL   (United States)

^e UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

AGED; ANGINA PECTORIS; ARTICLE; AUTOLOGOUS BPNE MARROW MONONUCLEAR CELL TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; CARDIOVASCULAR PROCEDURES; CHRONIC REFRACTORY ANGINA; CLINICAL ARTICLE; EXERCISE TOLERANCE; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; MALE; PERCUTANEOUS RETROGRADE CORONARY SINUS PERFUSION; PROGNOSIS; SAFETY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; AUTOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CHRONIC DISEASE; CLINICAL TRIAL; CORONARY SINUS; DEMOGRAPHY; EXERCISE; FEASIBILITY STUDY; HEART LEFT VENTRICLE FUNCTION; METHODOLOGY; MONONUCLEAR CELL; MYOCARDIAL PERFUSION IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PERFUSION; PHYSIOLOGY; TRANSPLANTATION; TREATMENT OUTCOME;

AGED; ANGINA PECTORIS; BONE MARROW TRANSPLANTATION; CHRONIC DISEASE; CORONARY SINUS; DEMOGRAPHY; EXERCISE; FEASIBILITY STUDIES; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MYOCARDIAL PERFUSION IMAGING; PERFUSION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 81255175539     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-9-183     Document Type: Article

References (22)

1. Jolicoeur EM, et al. Clinical and research issues regarding chronic advanced coronary artery disease part II: Trial design, outcomes, and regulatory issues. American heart journal 2008, 155(3):435-44. 10.1016/j.ahj.2007.12.005, 18294475.
2. Mannheimer C, et al. The problem of chronic refractory angina; report from the ESC Joint Study Group on the Treatment of Refractory Angina. European heart journal 2002, 23(5):355-70. 10.1053/euhj.2001.2706, 11846493.
3. Strauer BE, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002, 106(15):1913-8. 10.1161/01.CIR.0000034046.87607.1C, 12370212.
4. Wollert KC, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004, 364(9429):141-8. 10.1016/S0140-6736(04)16626-9, 15246726.
5. Schachinger V, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. Journal of the American College of Cardiology 2004, 44(8):1690-9. 10.1016/j.jacc.2004.08.014, 15489105.
6. Chen SL, et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. The American journal of cardiology 2004, 94(1):92-5. 10.1016/j.amjcard.2004.03.034, 15219514.
7. Schachinger V, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. The New England journal of medicine 2006, 355(12):1210-21. 10.1056/NEJMoa060186, 16990384.
8. Janssens S, et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 2006, 367(9505):113-21. 10.1016/S0140-6736(05)67861-0, 16413875.
9. Lipinski MJ, et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. Journal of the American College of Cardiology 2007, 50(18):1761-7. 10.1016/j.jacc.2007.07.041, 17964040.
10. Tse HF, et al. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 2003, 361(9351):47-9. 10.1016/S0140-6736(03)12111-3, 12517468.
11. Fuchs S, et al. Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study. Journal of the American College of Cardiology 2003, 41(10):1721-4. 10.1016/S0735-1097(03)00328-0, 12767654.
12. Perin EC, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003, 107(18):2294-302. 10.1161/01.CIR.0000070596.30552.8B, 12707230.
13. Briguori C, et al. Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina. American heart journal 2006, 151(3):674-80. 10.1016/j.ahj.2005.04.033, 16504630.
14. Losordo DW, et al. Intramyocardial, autologous CD34+ cell therapy for refractory angina. Circulation research 2011, 109(4):428-36. 10.1161/CIRCRESAHA.111.245993, 3190575, 21737787.
15. Giordano FJ. Retrograde coronary perfusion: a superior route to deliver therapeutics to the heart?*. Journal of the American College of Cardiology 2003, 42(6):1129-31. 10.1016/S0735-1097(03)00903-3, 13678942.
16. Boekstegers P, et al. Selective suction and pressure-regulated retroinfusion: an effective and safe approach to retrograde protection against myocardial ischemia in patients undergoing normal and high risk percutaneous transluminal coronary angioplasty. Journal of the American College of Cardiology 1998, 31(7):1525-33. 10.1016/S0735-1097(98)00135-1, 9626830.
17. Pohl T, et al. Retroinfusion-supported stenting in high-risk patients for percutaneous intervention and bypass surgery: results of the prospective randomized myoprotect I study. Catheterization and cardiovascular interventions: official journal of the Society for Cardiac Angiography & Interventions 2004, 62(3):323-30.
18. Raake P, et al. Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins: comparison with surgical and percutaneous intramyocardial gene delivery. Journal of the American College of Cardiology 2004, 44(5):1124-9. 10.1016/j.jacc.2004.05.074, 15337228.
19. von Degenfeld G, et al. Selective pressure-regulated retroinfusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemia. Journal of the American College of Cardiology 2003, 42(6):1120-8. 10.1016/S0735-1097(03)00915-X, 13678941.
20. Hoshino K, et al. Three catheter-based strategies for cardiac delivery of therapeutic gelatin microspheres. Gene therapy 2006, 13(18):1320-7. 10.1038/sj.gt.3302793, 16708077.
21. Hou D, et al. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation 2005, 112(9 Suppl):I150-6.
22. George JC, et al. Transvenous intramyocardial cellular delivery increases retention in comparison to intracoronary delivery in a porcine model of acute myocardial infarction. Journal of interventional cardiology 2008, 21(5):424-31. 10.1111/j.1540-8183.2008.00390.x, 19012733.